首页 | 本学科首页   官方微博 | 高级检索  
检索        

正交设计优选丹参-人参组分抗肝癌配伍研究
引用本文:毕蕾,颜晓静,杨烨,刘兴慈,陆映丹,陈卫平.正交设计优选丹参-人参组分抗肝癌配伍研究[J].中国实验方剂学杂志,2015,21(13):82-86.
作者姓名:毕蕾  颜晓静  杨烨  刘兴慈  陆映丹  陈卫平
作者单位:南京中医药大学 基础医学院, 南京 210023,南京中医药大学 基础医学院, 南京 210023,南京中医药大学 基础医学院, 南京 210023,南京中医药大学 基础医学院, 南京 210023,南京中医药大学 基础医学院, 南京 210023,南京中医药大学 基础医学院, 南京 210023
基金项目:国家自然科学基金项目(81072777, 81273638);江苏省高校自然科学研究项目(14KJD360004);江苏省高校优势学科建设工程项目(PAPD);江苏省2014年度普通高校研究生科研创新计划项目
摘    要:目的:优选丹参-人参活性组分抗肝癌优化配伍并对其作用机制作初步研究。方法:以人肝癌细胞SMMC-7721为研究对象,人正常肝细胞L-O2为对照,采用CCK-8法以对肝癌细胞增殖抑制和正常肝细胞保护作用为筛选指标,正交设计优选丹参-人参活性组分抗肝癌有效组合,确定优化配伍;应用实时细胞分析技术(RTCA DP)检测丹参-人参组分优化配伍对肝癌细胞SMMC-7721和正常肝细胞L-O2增殖的影响,并进行时效关系考察;采用Annexin V/PI双染法经高内涵细胞成像系统(HCS)检测丹参-人参组分优化配伍对肝癌细胞SMMC-7721凋亡的影响。结果:丹参-人参组分配伍抗肝癌SMMC-7721细胞的优化组合为丹参总酚酸、人参总皂苷和人参多糖,其配伍剂量分别为10,10,5 mg·L-1;优选的丹参-人参组分配伍能显著抑制肝癌细胞的增殖,呈现时间依赖性,而对正常肝细胞的增殖抑制作用不明显;丹参-人参组分优化配伍能诱导肝癌细胞凋亡,对正常肝细胞的凋亡无显著影响。结论:丹参-人参组分优化配伍具有潜在的特异选择性抗肝癌作用,其机制与抑制肝癌细胞增殖和诱导细胞凋亡相关。

关 键 词:丹参  人参  组分配伍  肝癌
收稿时间:8/7/2014 12:00:00 AM

Optimization of Effective Component Formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma on Hepatoma Carcinoma Using Orthogonal Design
BI Lei,YAN Xiao-jing,YANG Ye,LIU Xing-ci,LU Ying-dan and CHEN Wei-ping.Optimization of Effective Component Formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma on Hepatoma Carcinoma Using Orthogonal Design[J].China Journal of Experimental Traditional Medical Formulae,2015,21(13):82-86.
Authors:BI Lei  YAN Xiao-jing  YANG Ye  LIU Xing-ci  LU Ying-dan and CHEN Wei-ping
Institution:Department of Preclinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China,Department of Preclinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China,Department of Preclinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China,Department of Preclinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China,Department of Preclinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China and Department of Preclinical Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China
Abstract:Objective: To optimize the most effective component formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma on hepatoma carcinoma, and to reveal its antitumor mechanisms. Method: Human hepatoma cell SMMC-7721 was used as object and human normal liver cell line L-O2 was used as control in this study. The inhibiting effect on SMMC-7721 and the protective effect on L-O2 were performed by CCK-8 assay, and the most effective component formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma was optimized by using the orthogonal design method. The effect on SMMC-7721 and L-O2 viabilities were assayed by using Real-time cell assay and the time-effect relationship was analyzed. Cell apoptosis was measured by high content screening using Annexin V/PI double staining. Result: The results demonstrated that the contents of total salvianolic acid, total saponins Ginseng Radix et Rhizoma and ginseng polysaccharide doses were 10, 10, 5 mg·L-1, respectively, in the optimizing component formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma . Furthermore, the component formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma could significantly decrease the SMMC-7721 cell viability and induce SMMC-7721 cell apoptosis, while there was no significant difference on the normal liver cell. Conclusion: The component formula of Salviae Miltiorrhizae Radix et Rhizoma and Ginseng Radix et Rhizoma has potentially specific and selective anti-hepatoma carcinoma effect. Its mechanism may be related to the inhibition of hepatoma cell proliferation and induction of cell apoptosis.
Keywords:Salviae Miltiorrhizae Radix et Rhizoma  Ginseng Radix et Rhizoma  component formula  hepatoma carcinoma
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号